Oravital Inc. Showcasing its Advanced Periodontal Infection Diagnosis and Treatment System During its GNYDM Debut


Toronto, CA – November 9, 2015 – Oravital Inc., which recently launched the Oravital® periodontal and breath odor diagnosis and treatment system into the U.S. professional dental market, will be making its debut at the Greater New York Dental Meeting at the Jacob K. Javits Convention Center at booth # 3838 from November 29th through December 2nd.

According to company president and CEO Dr. Jim Hyland, “We are very excited about our debut at the Greater New York Dental Meeting. We’ve learned from our experience in Canada, that speaking to dentists and hygienists in person is very important for creating brand awareness. We have also learned that dental professionals are looking for a system to predictably control gingival bleeding and breath odors.”

Throughout the meeting, Oravital® will be offering a show special of $995 ($1,295 value) for its oral infection diagnosis, treatment and coaching system Platinum Package.  In addition, Dr. Hyland, DDS BSc, and his clinical management team consisting of Chief Science Officer Anne Bosy, RRDH, MEd, MSc, and Clinical Hygiene Educator Kerry Lepiciek, RDH, will be on hand to explain the efficacy and application of the proprietary Oravital® System, which is indicated for the treatment of both periodontal disease and halitosis, and consists of the following five steps:

1.    Diagnosis employing, in addition to periodontal charting, the use of a Papillary Bleeding Score and oral microbial reports using Gram stain or DNA analysis.
2.    Treatment using a prescribed Oravital® antibiotic and/or antimicrobial rinse specifically targeted to eliminate particular biofilm pathogens causing the oral infection.
3.    Evaluation following initial treatment to document changes and plan additional therapy if needed.
4.    Maintenance encouraging regular dental hygiene appointments and good oral home care consisting of regular brushing and cleaning between their teeth, and using an Oravital® maintenance rinse on a daily basis.

5.    Monitoring health by determining through Oravital® microbial testing at least once a year and through periodontal diagnostic testing as to whether the oral biofilm is still in balance.

“Undiagnosed and untreated oral infections are a North American epidemic and include gum disease and halitosis,” explains Hyland. “We also know that gum disease is a contributing factor to many systemic conditions such as cardiovascular disease, Alzheimer’s and diabetes, because the infection spreads via bacteremia. The Oravital® system can have a very positive impact on the overall health of the patient.”

For more information on the Oravital® system and how your dental practice can become a certified Oravital® Clinic, visit www.oravital.com or call 1-800-909-6468.

About Oravital Inc.

Oravital Inc. was established in the fall of 2007 in Toronto, Canada. The company licenses proprietary technology called the Oravital® System to certified dental clinics throughout North America for the most advanced, effective and painless diagnosis and treatment of oral infections available today.
Previously, oral infections causing periodontal disease and bad breath had been difficult to diagnose and treat successfully.  With recent studies linking oral infections with systemic conditions such as heart disease and diabetes, periodontal disease is now considered a medical condition dental professionals should treat. Given that 75% of the population continues to have signs of periodontal disease, in spite of our best efforts, diagnosis and predictable treatment of this infection has become extremely important.   
Biofilm testing and the use of antibiotic rinses dramatically halt the progress of periodontal disease and breath odor.  Bleeding is reduced by 87%, and pocket depths shrink by 76 to 84% within a few weeks. Oravital® proprietary rinses treat the entire oral complex and are non-systemic.  If one kills the bacteria causing the problem, patients heal quickly.  The Oravital® system is the only system to predictably treat the oral systemic link.
The Oravital® System is highly effective in eliminating mild to moderate gum disease as well as bad breath. The Oravital® System is based on identifying the cause of oral infection through inexpensive microbial analysis and repeatable objective tests for bleeding gums. Treatment includes a customized antibiotic rinse used for a two-week period, followed by two weeks of antimicrobial rinses.  This treatment regimen is accompanied by unique gum cleaning techniques for the patient to follow.
The science of Oravital® evolved from 15 years of ground-breaking research and successful clinical treatment by Anne Bosy, RRDH, MEd, MSc, co-founder of Toronto's Fresh Breath Clinic. Dr. Walter Loesche, who was a respected authority on periodontal disease treatment at the University of Michigan, validated the effectiveness of the antibiotic therapy developed by Anne Bosy.  

Oravital Inc. also provides a comprehensive, dynamic and scientifically-grounded training program to its clinics. Oravital® certified dental professionals are authorized experts in providing Oravital® diagnostic analysis, individualized treatment, and dedicated long-term support. For more information, visit www.oravital.com or call 1-800-909-6468.
# # #